Immunocore Holdings plc (IMCR) Revenue 2021–2025
Immunocore Holdings plc (IMCR) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$400.0MFY2025 · since FY2021: $4.1M → $400.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $400.0M | +29.0% |
| FY2024 | $310.2M | +24.4% |
| FY2023 | $249.4M | +43.1% |
| FY2022 | $174.4M | +4175.6% |
| FY2021 | $4.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More IMCR financial trends
IMCR Net incomeIMCR Net marginIMCR Gross profitIMCR Gross marginIMCR Operating incomeIMCR Operating marginIMCR Operating cash flowIMCR Free cash flowIMCR Capital expendituresIMCR Return on equityIMCR Stock buybacksIMCR Dividends paidIMCR Total assetsIMCR Total liabilitiesIMCR Shareholders’ equityIMCR overview →